Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1973 Apr;24(4):721–733.

Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency

M P Dierich, D Bitter-Suermann, W König, U Hadding, C Galanos, E T Rietschel
PMCID: PMC1422903  PMID: 4122408

Abstract

Endotoxic lipopolysaccharides prepared from Salmonella minnesota smooth form (LPS-S) and rough form, R 595 (LPS-R) activate C3 in guinea-pig serum as is demonstrated by C3 kinetics and generation of anaphylatoxic activity. The activation depends on the presence of certain serum factors, one of which is the protein (SF) interacting with the cobra venom factor, on the presence of Mg++, the temperature and on dose of LPS applied.

This turnover of C3 is terminated at 37° within 2 minutes (LPS-R) to 12 minutes (LPS-S) and then reaches a plateau. The amount of C3 consumption, i.e. the level of the plateau, is typical for given concentrations of LPS-S and LPS-R (intermediate plateau). Above a certain LPS-concentration additional LPS does not induce further C3 turnover (maximal plateau). While the `maximal plateau' may be explained by a limitation of the factors needed for the LPS dependent consumption of C3, the `intermediate plateau' and the termination of the action on C3 are not well understood. It is hypothesized that coating of the LPS molecule by serum protein, e.g. albumin, inactivates LPS-S and LPS-R with regard to their action on C3. C3 and C5 in normal serum concentrations appear not to be involved. It is suggested that an additional mechanism for termination of LPS action is a rapid loss of activity of LPS-induced intermediates.

Full text

PDF
721

Images in this article

729FIG. 8
on p.729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend P., Springer G. F. Mechanismus und Spezifität der Endotoxinbindung an Zellmembranen. Arzneimittelforschung. 1971 Oct;21(10):1506–1509. [PubMed] [Google Scholar]
  2. Bitter-Suermann D., Dierich M., König W., Hadding U. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology. 1972 Sep;23(3):267–281. [PMC free article] [PubMed] [Google Scholar]
  3. Bitter-Suermann D., Hadding U., Melchert F., Wellensiek H. J. Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry. 1970 Dec;7(12):955–965. doi: 10.1016/0019-2791(70)90002-9. [DOI] [PubMed] [Google Scholar]
  4. Chedid L., Parant M., Parant F., Boyer F. A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol. 1968 Feb;100(2):292–306. [PubMed] [Google Scholar]
  5. Davis S. D., Gemsa D., Wedgwood R. J. Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol. 1966 Apr;96(4):570–577. [PubMed] [Google Scholar]
  6. Dierich M. P., Bitter-Suermann D., König W., Hadding U. Formation and function of a complement-activating enzyme generated from factors of guinea pig serum and cobra venom. Eur J Immunol. 1971 Aug;1(4):309–311. doi: 10.1002/eji.1830010421. [DOI] [PubMed] [Google Scholar]
  7. Edelman G. M., Rutishauser U., Millette C. F. Cell fractionation and arrangement on fibers, beads, and surfaces. Proc Natl Acad Sci U S A. 1971 Sep;68(9):2153–2157. doi: 10.1073/pnas.68.9.2153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fong J. S., Good R. A. Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor. J Exp Med. 1971 Sep 1;134(3 Pt 1):642–655. doi: 10.1084/jem.134.3.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frank M. M., May J., Gaither T., Ellman L. In vitro studies of complement function in sera of C4-deficient guinea pigs. J Exp Med. 1971 Jul 1;134(1):176–187. doi: 10.1084/jem.134.1.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galanos C., Lüderitz O., Westphal O. Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem. 1971 Dec 22;24(1):116–122. doi: 10.1111/j.1432-1033.1971.tb19661.x. [DOI] [PubMed] [Google Scholar]
  11. Galanos C., Rietschel E. T., Lüderitz O., Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem. 1971 Mar 1;19(1):143–152. doi: 10.1111/j.1432-1033.1971.tb01298.x. [DOI] [PubMed] [Google Scholar]
  12. Gewurz H., Pickering R. J., Snyderman R., Lichtenstein L. M., Good R. A., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharides in immunoglobulin-deficient sera. J Exp Med. 1970 Apr 1;131(4):817–831. doi: 10.1084/jem.131.4.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med. 1968 Nov 1;128(5):1049–1057. doi: 10.1084/jem.128.5.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Glynn A. A. The complement lysozyme sequence in immune bacteriolysis. Immunology. 1969 Apr;16(4):463–471. [PMC free article] [PubMed] [Google Scholar]
  15. Marcus R. L., Shin H. S., Mayer M. M. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1351–1354. doi: 10.1073/pnas.68.6.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
  17. Sandberg A. L., Osler A. G. Dual pathways of complement interaction with guinea pig immunoglobulins. J Immunol. 1971 Nov;107(5):1268–1273. [PubMed] [Google Scholar]
  18. Skarnes R. C. Host defense against bacterial endotoxemia: mechanism in normal animals. J Exp Med. 1970 Aug 1;132(2):300–316. doi: 10.1084/jem.132.2.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zimmerman T. S., Müller-Eberhard H. J. Blood coagulation initiation by a complement-mediated pathway. J Exp Med. 1971 Dec 1;134(6):1601–1607. doi: 10.1084/jem.134.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES